Patents by Inventor Elizabeth A. McLaughlin

Elizabeth A. McLaughlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10746743
    Abstract: There is provided herein a method for identifying and/or recovering at least one genetically encoded affinity reagent specific for a target molecule by screening using molecular display in conjunction with the sequencing of positive and negative selection pools from the screen.
    Type: Grant
    Filed: November 7, 2016
    Date of Patent: August 18, 2020
    Assignee: The Governing Council of the University of Toronto
    Inventors: Sachdev Sidhu, Jason Moffat, Helena Persson, Nish Patel, Saravanan Sundararajan, Amandeep Gakhal, Wei Ye, Jelena Tomic, Megan Elizabeth Mclaughlin
  • Publication number: 20170184608
    Abstract: There is provided herein a method for identifying and/or recovering at least one genetically encoded affinity reagent specific for a target molecule by screening using molecular display in conjunction with the sequencing of positive and negative selection pools from the screen.
    Type: Application
    Filed: November 7, 2016
    Publication date: June 29, 2017
    Inventors: Sachdev Sidhu, Jason Moffat, Helena Persson, Nish Patel, Saravanan Sundararajan, Amandeep Gakhal, Wei Ye, Jelena Tomic, Megan Elizabeth Mclaughlin
  • Publication number: 20010051374
    Abstract: A method is provided for producing a population of genetically modified T cells. In the method, an in vitro population of T cells is activated by contacting said population with a CD3 binding agent. Genetic modification is then carried out with the activated T cells by contacting the same with a suitable gene transfer vector.
    Type: Application
    Filed: December 3, 1999
    Publication date: December 13, 2001
    Inventors: ELIZABETH MCLAUGHLIN-TAYLOR, MARK KRUGER, CHERYL LUNDAK, CATHERINE KILLION
  • Patent number: 6114113
    Abstract: A method is provided for producing a population of genetically modified T cells. In the method, an in vitro population of T cells is activated by contacting said population with a CD3 binding agent. Genetic modification is then carried out with the activated T cells by contacting the same with a suitable gene transfer vector.
    Type: Grant
    Filed: August 11, 1998
    Date of Patent: September 5, 2000
    Assignee: Chiron Corporation
    Inventors: Elizabeth McLaughlin-Taylor, Mark Kruger, Cheryl Lundak, Catherine Killion
  • Patent number: 5415047
    Abstract: A weld joint test fixture for testing the strength of a weld joining seve members forming a test specimen is provided. The fixture includes a base which supports the test specimen and an attachment for applying a testing force to the test specimen while the test specimen is supported by the base. The fixture further includes holding elements attached to the base for holding the test specimen on the base during the application of the testing force. The holding elements preferably engage one of the members forming the test specimen without engaging another of the members. The fixture may also include the holding elements being designed to oppose the testing force substantially only by forces directed in a plane parallel to the applied testing force.
    Type: Grant
    Filed: June 9, 1994
    Date of Patent: May 16, 1995
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: Wendell C. Maciejewski, Kurt J. Janecek, George J. Kavarnos, Elizabeth A. McLaughlin
  • Patent number: D795337
    Type: Grant
    Filed: August 25, 2015
    Date of Patent: August 22, 2017
    Assignee: ADOBE SYSTEMS INCORPORATED
    Inventors: Paul D. Hunt, Erin Elizabeth McLaughlin